Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 3
1985 2
1986 2
1987 1
1988 2
1989 1
1990 1
1996 1
1998 1
2005 1
2008 1
2011 1
2015 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease.
Feagan BG, Sandborn WJ, D'Haens G, Lee SD, Allez M, Fedorak RN, Seidler U, Vermeire S, Lawrance IC, Maroney AC, Jurgensen CH, Heath A, Chang DJ. Feagan BG, et al. Among authors: jurgensen ch. Aliment Pharmacol Ther. 2015 Nov;42(10):1170-81. doi: 10.1111/apt.13398. Epub 2015 Sep 23. Aliment Pharmacol Ther. 2015. PMID: 26400458 Free article. Clinical Trial.
P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K.
Barrett DG, Boncek VM, Catalano JG, Deaton DN, Hassell AM, Jurgensen CH, Long ST, McFadyen RB, Miller AB, Miller LR, Payne JA, Ray JA, Samano V, Shewchuk LM, Tavares FX, Wells-Knecht KJ, Willard DH Jr, Wright LL, Zhou HQ. Barrett DG, et al. Among authors: jurgensen ch. Bioorg Med Chem Lett. 2005 Aug 1;15(15):3540-6. doi: 10.1016/j.bmcl.2005.05.062. Bioorg Med Chem Lett. 2005. PMID: 15982880
Activated human T cells can present denatured antigen.
Gerrard TL, Volkman DJ, Jurgensen CH, Fauci AS. Gerrard TL, et al. Among authors: jurgensen ch. Hum Immunol. 1986 Dec;17(4):416-25. doi: 10.1016/0198-8859(86)90301-0. Hum Immunol. 1986. PMID: 3491814
19 results